Skip to main content
Article
An open‐label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer
Cancer (2012)
  • Phuong Khanh Morrow, University of Texas MD Anderson Cancer Center
  • Rashmi K. Murthy, University of Texas MD Anderson Cancer Center
  • Joe D. Ensor, University of Texas MD Anderson Cancer Center
  • Gilad S. Gordon
  • Kim A. Margolin, University of Washington
  • Anthony D. Elias, University of Colorado Denver
  • Walter J. Urba, Providence Portland Medical Center
  • David E. Weng
  • Hope S. Rugo, University of California, San Francisco
  • Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center
Publication Date
September 1, 2012
DOI
10.1002/cncr.26730
Citation Information
Phuong Khanh Morrow, Rashmi K. Murthy, Joe D. Ensor, Gilad S. Gordon, et al.. "An open‐label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer" Cancer Vol. 118 Iss. 17 (2012) p. 4098 - 4104
Available at: http://works.bepress.com/walter-urba/152/